Your post is written in a gross misunderstanding that Lexaria's business is making and selling products. That is far from the truth.
Lexaria is foremost a company that licenses their technology to others who have the products, facilities, and means to create sales of their own products and pay licensing and royalty money to Lexaria for use of their drug delivery technology.
Lexaria has no facility to create it's own products. The CBD products that Lexaria have come up with were an attempt to drum up some extra revenue to help them pay bills on the way to becoming a pure technology company. The fact that these ventures have not been overly successful yet is not that important in the big "Game Plan". Sure, it would be nice if they were selling better and things could still open up in the U.S. CBD Market. The Canadian CBD market is just getting started as well. Soon, Hill Street Beverages will be selling powdered CBD and THC packages along with compressed pills. Also, they will soon be selling a world class selection of wine and beer infused with Lexaria's technology.
The Altria deal is the biggest deal Lexaria's been involved with so far and although it is currently in a state of limbo, it cannot be written down as a complete failure of Bunka. Altria still has a licensing deal with Lexaria to pay them royalties for any oral nicotine product using Lexaria's technology that they sell. Altria, although playing aloof, has not cancelled anything with Lexaria.
Lexaria has not conveniently jumped on the COVID train to divert attention away from the Altria deal. Lexaria happens to have one of the most impressive new technologies that is able to take a great many different types of drugs and deliver them orally in a much more efficient way than presently exists in the marketplace. Lexaria's technology is extremely well suited to take antiviral medications, sometimes intravenous, and make them accessible to the world in a far more viable format. This is a potentially a huge lifesaving move by Lexaria. It also fits in with their plan of entering the Pharmaceutical Industry with their technology.
If you personally don't believe in Lexaria, as seems evident by your continual mocking of them, there are many other companies out there to invest in.
News 
Market Data 
Discover 
AI
